p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression

Area of Science:

• Molecular Biology
• Cancer Research
• Biochemistry

Background:

• The tumor suppressor protein p53 plays a critical role in preventing cancer.
• The precise mechanisms by which p55 suppresses tumorigenesis are not fully understood.
• The mevalonate pathway is essential for synthesizing cholesterol and nonsterol isoprenoids.

Purpose of the Study:

• To investigate a novel role of p53 in suppressing the mevalonate pathway.
• To elucidate the molecular mechanisms underlying p53-mediated tumor suppression in the liver.
• To explore therapeutic strategies targeting the mevalonate pathway in liver cancer.

Main Methods:

• Utilized a mouse model of liver cancer.
• Investigated the transcriptional regulation of the mevalonate pathway by p53.
• Employed pharmacological and RNA interference (RNAi) inhibition strategies.
• Assessed SREBP-2 activation and ABCA1 cholesterol transporter gene expression.

Main Results:

• p53 suppresses tumorigenesis by inhibiting the mevalonate pathway.
• p53 blocks SREBP-2 activation through transcriptional induction of the ABCA1 gene.
• Inhibition of the mevalonate pathway restricts hepatocellular carcinoma development in p53-deficient mice.
• Loss of p53 or ABCA1 promotes liver tumorigenesis, associated with increased SREBP-2 maturation.

Conclusions:

• Repression of the mevalonate pathway is a key mechanism of p53-mediated liver tumor suppression.
• Targeting the mevalonate pathway represents a potential therapeutic approach for liver cancer.
• This study reveals a novel link between p53, cholesterol biosynthesis, and liver cancer prevention.